PT462 – Touch Therapy, Wearable Technology, and Treating Trauma with Safety

November 21, 2023
Featuring: Dr. Dave Rabin, MD, Ph.D.

In this episode, Joe interviews neuroscientist, board-certified psychiatrist, health tech entrepreneur, inventor, and Co-Founder & Chief Medical Officer at Apollo Neuro: Dr. Dave Rabin, MD, Ph.D.

Subscribe Share

In this episode, Joe interviews neuroscientist, board-certified psychiatrist, health tech entrepreneur, inventor, and Co-Founder & Chief Medical Officer at Apollo Neuro: Dr. Dave Rabin, MD, Ph.D.

He talks about his path to psychiatry; his realization that trauma and chronic stress were primary themes at the root of most mental illness; and the creation, research and implementation of the Apollo wearable: the first scientifically-validated wearable technology designed to improve energy, focus, and relaxation based on touch therapy. The idea was born from Rabin asking himself: If we’re all starved for touch and constantly feeling unsafe, our bodies prefer a calm, soothed state, and MDMA seems to work by amplifying feelings of safety and essentially telling our brains, “you’re safe enough to heal now,” could a rhythmic vibration programmed to stimulate touch receptors and put our bodies into a meditative state fool our brains into the same perceived feeling of safety – especially if that stimulation is constant? Would our nervous systems be able to tell the difference? So far, the data seems to prove that this technology works.

He discusses what they learned from initial research about how people were using their Apollo wearables; heart rate variability and what changes it; MAPS’ Phase III MDMA-assisted psychotherapy results; the idea of the inner healer; using the Apollo in conjunction with ketamine and other psychedelics to ease pre-experience anxiety; and the concept of MDMA-assisted psychotherapy as reverse trauma, the reality that it could stop epigenetic memory, and the question of whether or not the Apollo can do this on its own.

Apollo Neuro is continuing their research by running 14 different trials right now, and if you ever participated in a MAPS trial, you’re eligible for a free wearable. If you’re just curious about trying the Apollo, you can receive $50 off using this link.

Notable Quotes

“What we’ve learned through the study of all the work that came before us was that the body actually likes to be in that state. It likes to be in this calm, soothed state, and it’s just overwhelmed and overstimulated a lot of the time and that’s why it’s not in that state. So then the research question was: If we deliver the rhythm that our bodies like to breathe at when they’re at rest (which is like five to seven breaths per minute when we’re normally breathing at 12 to 24 breaths per minute, which is stress breathing), then would the body start to automatically breathe at its ideal rhythm on its own simply by receiving the right rhythm? Is that enough? Like, if you play the right dance beat, will people start dancing on their own or will they just sit in the chair?”

“The word ‘hallucination’ implies that what you’re experiencing is not real, and I hesitate to use that word in the context of psychedelic work because ‘psychedelic’ means to reveal the mind. And so, if we put out the understanding that the revelation of what’s underneath the surface of our consciousness in our minds is not real or hallucinatory, then we might be missing a lot of the meaning of what’s actually underneath the surface.”

“If we are able to show that other safety-based treatments, whether it’s MDMA or traditional ceremonial ayahuasca or other things, or ketamine therapy, or Apollo, or soothing touch: If any of these things are inducing similar changes to cortisol receptors that we saw in that MDMA trial, then we know it’s not the drug that is inducing the healing state. It’s the safety that is amplified by the drug that produces the healing response. And that will be really, really helpful to us as a field to understand what we actually need to heal. I think the theory is [that] we need to feel safe enough to heal. This would actually prove that.”

Links studies roundup

Saving Normal: An Insider’s Revolt Against Out-Of-Control Psychiatric Diagnosis, DSM-5, Big Pharma, and the Medicalization of Ordinary Life, by Allen Frances, M.D.

The Psychedelic Report: Can MDMA-Assisted Therapy Repair our Epigenetics with Dr. Candace Lewis PhD

Your Brain Explained: Breaking Down Trauma w/ Dr. Gabor Maté & Dr. Rachel Yehuda

Apollo Neuro: Click here to get $50 off an Apollo wearable!

Dr. Dave Rabin_ MD_ Ph.D 4

In this Episode

Dr. Dave Rabin, MD, Ph.D.

Dr. David Rabin, MD, Ph.D., is a neuroscientist, board-certified psychiatrist, health tech entrepreneur, and inventor who has been studying the impact of chronic stress in humans for more than a decade. He is the Co-Founder & Chief Medical Officer at Apollo Neuro, which has developed the first scientifically-validated wearable technology that actively improves energy, focus & relaxation, using a novel touch therapy that signals safety to the brain.
Dr. Dave has always been fascinated by consciousness and our inherent ability to heal ourselves from injury and illness. As such, he has specifically focused his research on the clinical translation of non-invasive therapies for patients with treatment-resistant illnesses like PTSD and substance use disorders.

Dr. Rabin is the Co-Founder and Executive Director of the Board of Medicine, a 501(c)(3) nonprofit organization of physicians and scientists establishing the first peer-reviewed, evidence-based clinical guidelines for the production and safe use of currently unregulated alternative medicines, including plant medicines. The Board of Medicine trains and certifies healthcare providers, and provides quality control standards for complementary and alternative medicines to support high-quality clinical research, best practices, and risk-reduction. In addition to his clinical psychiatry practice, Dr. Dave is currently conducting research on the epigenetic regulation of trauma responses and recovery to elucidate the mechanism of psychedelic-assisted psychotherapy and the neurobiology of belief. Dr. Rabin received his MD in medicine and Ph.D. in neuroscience from Albany Medical College and specialized in psychiatry with a distinction in research at Western Psychiatric Institute & Clinic at the University of Pittsburgh Medical Center.
He has been married to his co-founder, Kathryn Fantauzzi, since 2016.

Socials: Instagram / Clubhouse / Linkedin